Utilizing Peptide Ligand GPCRs to Image and Treat Pancreatic Cancer
It is estimated that early detection of pancreatic ductal adenocarcinoma (PDAC) could increase long-term patient survival by as much as 30% to 40% (Seufferlein, T. et al., Nat. Rev. Gastroenterol. Hepatol. 2016, 13, 74–75). There is an unmet need for reagents that can reliably identify early c...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2018-06-01
|
| Series: | Biomedicines |
| Assuntos: | |
| Acceso en liña: | http://www.mdpi.com/2227-9059/6/2/65 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|